U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C27H29NO11
Molecular Weight 543.5193
Optical Activity UNSPECIFIED
Defined Stereocenters 6 / 6
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of EPIRUBICIN

SMILES

[H][C@@]1(C[C@H](N)[C@@H](O)[C@H](C)O1)O[C@H]2C[C@@](O)(CC3=C(O)C4=C(C(=O)C5=C(OC)C=CC=C5C4=O)C(O)=C23)C(=O)CO

InChI

InChIKey=AOJJSUZBOXZQNB-VTZDEGQISA-N
InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22-,27-/m0/s1

HIDE SMILES / InChI

Molecular Formula C27H29NO11
Molecular Weight 543.5193
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 6 / 6
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Fri Dec 15 15:51:39 UTC 2023
Edited
by admin
on Fri Dec 15 15:51:39 UTC 2023
Record UNII
3Z8479ZZ5X
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
EPIRUBICIN
HSDB   INN   MI   VANDF   WHO-DD  
INN  
Official Name English
5,12-NAPHTHACENEDIONE, 10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-ARABINO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(HYDROXYACETYL)-1-METHOXY-, (8S-CIS)-
Common Name English
EPIADRIAMYCIN
Common Name English
EPIDOXORUBICIN
Common Name English
(1S,3S)-3-GLYCOLOYL-1,2,3,4,6,11-HEXAHYDRO-3,5,12-TRIHYDROXY-10-METHOXY-6,11-DIOXO-1-NAPHTHACENYL 3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-ARABINO-HEXOPYRANOSIDE
Common Name English
EPIRUBICIN [HSDB]
Common Name English
4'-EPI-ADRIAMYCIN
Common Name English
EPIRUBICINE
Common Name English
Epirubicin [WHO-DD]
Common Name English
EPIRUBICIN [VANDF]
Common Name English
NSC-256942
Code English
FARMORUBICIN
Brand Name English
EPIRUBICIN [MI]
Common Name English
epirubicin [INN]
Common Name English
Classification Tree Code System Code
LIVERTOX NBK548622
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
NDF-RT N0000000176
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
NDF-RT N0000007530
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
FDA ORPHAN DRUG 588517
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
WHO-ATC L01DB03
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
NDF-RT N0000175414
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
FDA ORPHAN DRUG 121498
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
WHO-VATC QL01DB03
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
NCI_THESAURUS C1594
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
NDF-RT N0000007530
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
NDF-RT N0000007530
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
Code System Code Type Description
INN
5171
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
PRIMARY
EVMPD
SUB06571MIG
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
PRIMARY
RXCUI
3995
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
PRIMARY RxNorm
MESH
D015251
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
PRIMARY
CAS
56420-45-2
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
PRIMARY
HSDB
6962
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
PRIMARY
MERCK INDEX
m4948
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
PRIMARY Merck Index
CHEBI
47898
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
PRIMARY
FDA UNII
3Z8479ZZ5X
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
PRIMARY
EPA CompTox
DTXSID0022987
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
PRIMARY
NCI_THESAURUS
C62028
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
PRIMARY
WIKIPEDIA
EPIRUBICIN
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
PRIMARY
DRUG CENTRAL
1030
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
PRIMARY
DAILYMED
3Z8479ZZ5X
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
PRIMARY
NSC
256942
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
PRIMARY
DRUG BANK
DB00445
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
PRIMARY
PUBCHEM
41867
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
PRIMARY
SMS_ID
100000080474
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
PRIMARY
ChEMBL
CHEMBL417
Created by admin on Fri Dec 15 15:51:39 UTC 2023 , Edited by admin on Fri Dec 15 15:51:39 UTC 2023
PRIMARY
Related Record Type Details
BINDER->LIGAND
BINDING
TRANSPORTER -> SUBSTRATE
SALT/SOLVATE -> PARENT
TRANSPORTER -> SUBSTRATE
Related Record Type Details
METABOLITE -> PARENT
MAJOR
METABOLITE -> PARENT
The mean metabolite/parent AUC ratio is about 25% for 7-deoxydoxorubicin aglycone
METABOLITE -> PARENT
The mean metabolite/parent AUC ratio is about 15% for doxorubicin aglycone
METABOLITE -> PARENT
The mean metabolite/parent AUC ratio is about 20% for epirubicin glucuronide
MAJOR
PLASMA
METABOLITE -> PARENT
The mean metabolite/parent AUC ratio is about 25% for epirubicinol glucuronide
METABOLITE -> PARENT
The mean metabolite/parent AUC ratio is about 4% 7-deoxydoxorubicinol aglycone
METABOLITE -> PARENT
The mean metabolite/parent AUC ratio is about 15% for doxorubicinol aglycone
PRODRUG -> METABOLITE ACTIVE
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC
Volume of Distribution PHARMACOKINETIC